4th Quarter - Report

K&L GATES, LLP for OMEROS CORPORATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to packaging of certain drug therapies under Medicare Part B, including H.R. 4679 - Ensuring Equal Access to Treatments Act of 2017 and H.R. 4683 - To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medicare outpatient prospective payment system.

LobbyistCovered position, as disclosed
AMY CARNEVALE New Staff Aide, Office of Natl. Drug Control Policy ; LA, LD, Chief of Staff, Rep. George Nethercutt, Jr.
STACY ETTINGER New Staff Atty/Chief, AD/CVD Regulation/Assoc Ch Cnsl, DoC, Office of Genl Cnsl; Trade Cnsl detailee from DoC to JEC; Dep Staff Dir, JEC; Sr Cnsl, Sen Schumer; Sr Cnsl/Acting Dep Staff Dir/Ch Cnsl/Dem Ch Cnsl, Sen Comm Rules & Admin
BART GORDON —
RODERICK D. HALL —
AMANDA MAKKI New Confidential Asst, Dept. of Army, DOD; Legal Intern, HELP Comm.; Senior Health Advisor, Rep. Fortenberry; Senior Health Adviisor, Sen. Murkowski
KARISHMA SHAH PAGE —
DENNIS POTTER —
DANIEL RITTER —
CORBIN SANTO —
STEVEN RICHARDS VALENTINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4679 (115th), H.R. 4683 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.